Virtual Medicinal Product (VMP)
-
Estropipate 1.5mg tablets
Name Details
Current Name
Estropipate 1.5mg tablets
|
Start Date
19-11-2002
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03CA57
BNF |
Current BNF
06040101
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040101
|
Start Date
23-02-2005
|
End Date
04-11-2010
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41876211000001104 |
26-05-2023 |
|
325560001 |
19-11-2002 |
25-05-2023 |
VMP Ingredients
VMP ingredients table
Estropipate |
Based on Ingredient Substance |
|
1.5 mg |
|
Name
Estropipate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
1.5
Strength and UOM (Dmr)
Parent Products
-
VTM
Estropipate
-
VMP
(Current) Estropipate 1.5mg tablets
Virtual Medicinal Product Pack (VMPP) Information